Linc currently has around twenty investments in companies based in the Nordic Life Science market. We are an active owner in all our portfolio companies. We make investments in two main sub-sectors of the life science market; medical technology and pharmaceuticals. Our portfolio companies are product oriented and have global ambitions.
In the medical technology sector, the portfolio companies are typically in a later stage of development and in most cases have products on the market and an established market position. Our initial investments in pharmaceutical companies usually take place in the clinical development phase, ie relatively early in the company’s development.